Lee's Pharmaceutical Holdings has added to its list of licensing partners through an agreement with the private Swedish drug development firm Dilafor for Chinese rights to tafoxiparin.
written on 24.02.2014
Lee's Pharmaceutical Holdings has added to its list of licensing partners through an agreement with the private Swedish drug development firm Dilafor for Chinese rights to tafoxiparin.
See our Cookie Privacy Policy Here